Ann Kurth, PhD, MPH, MSN, CNM, FAAN
About
Research
Publications
2025
Impact of scaling up harm reduction interventions on injecting risk behaviours, ART outcomes and HIV incidence among people who inject drugs in Kenya
Walker J, Akiyama M, Artenie A, Cleland C, Lizcano J, Musyoki H, Nyakowa M, Cherutich P, Kurth A, Vickerman P. Impact of scaling up harm reduction interventions on injecting risk behaviours, ART outcomes and HIV incidence among people who inject drugs in Kenya. International Journal Of Drug Policy 2025, 140: 104824. PMID: 40328143, DOI: 10.1016/j.drugpo.2025.104824.Peer-Reviewed Original ResearchConceptsOpioid agonist therapyHIV incidenceAssociated with lower HIV incidenceEffectiveness of HIV prevention interventionsViral suppressionRisk behaviorsReduced risk of HIV acquisitionIncrease ART uptakeHIV prevention interventionsRisk of HIV acquisitionLower HIV incidenceBio-behavioural surveyHIV viral loadProportion of peopleRespondent-driven samplingART uptakeDried blood spot samplesHIV outcomesReduction interventionsPreventive interventionsART coverageBlood spot samplesInjection risk behaviorsEvidence gapsHIV acquisitionHealth promotion messaging reduces HIV risk behaviours and improves repeat testing among adolescent girls and young women in Kenya
Ochillo M, Bosire R, Okeyo N, Onyango J, Agot K, Chhun N, Rao S, Kurth A, Inwani I. Health promotion messaging reduces HIV risk behaviours and improves repeat testing among adolescent girls and young women in Kenya. African Journal Of AIDS Research 2025, ahead-of-print: 1-6. PMID: 40259692, DOI: 10.2989/16085906.2025.2474751.Peer-Reviewed Original ResearchDeliver health promotion messagesHIV-negative cohortMobile phone text messagesRisky sexual behaviorReduction of risky sexual behaviorsHealth promotion messagesHealth intervention programmesHIV-negative AGYWSexual health promotionPhone text messagingPartner's HIV statusYoung peopleReducing risky sexual behaviorStudy follow-up periodPromote safer sex behaviorsAdolescent girlsSexually active AGYWHIV risk behaviorsYoung womenHigh-risk adolescent girlsHealth promotionMobile healthHealth servicesSafer sex behaviorsMultiple sexual partnershipsFrom Vulnerability to Strength: Transforming Health Systems for Climate Resilience
Hussain M, Khan N, Morton G, Kieffer E, Kurth A. From Vulnerability to Strength: Transforming Health Systems for Climate Resilience. Journal Of Urban Health 2025, 1-12. PMID: 40183975, DOI: 10.1007/s11524-025-00972-1.Peer-Reviewed Original ResearchHealthcare systemExacerbate health disparitiesTransforming health systemsPublic health practiceEnhance healthcare deliveryResilience of healthcare systemsHealth disparitiesHealth workersHealthcare deliveryHealth practicesHealth systemResilient workforceData-driven planningHealthcare infrastructureCommunity engagementMultifaceted approachFunding supportVulnerable communitiesRising costsComprehensive approachHealthcareCOVID-19Proactive measuresHealthCommunityFour Opportunities To Revitalize The US Biomedical Research Enterprise
Reece E, Balser J, Bibbins-Domingo K, Fraser C, Fried L, Kurth A, Parikh S, Rutta R, Woolley M, Yamamoto K, Zerhouni E, Zoghbi H, Dzau V. Four Opportunities To Revitalize The US Biomedical Research Enterprise. Health Affairs 2025, 44: 140-147. PMID: 39841931, DOI: 10.1377/hlthaff.2024.01001.Peer-Reviewed Original ResearchConceptsNational Academy of Medicine's Vital DirectionsBiomedical research enterpriseReduce health disparitiesHealth equity gapsComplex health issuesNational health outcomesResearch enterpriseFederal research fundingHealth disparitiesResearch fundingWorkforce recruitmentHealth outcomesRetention challengesPromote healthy longevityHealth issuesHealthy longevityVital directionsEquity gapNational Advisory BodyWorkforceNational AcademyPriorityDisparitiesFundingGlobal competitionBarriers to and impacts of hepatitis C treatment among people who inject drugs in Kenya: A qualitative study
Manley H, Riback L, Nyakowa M, Akiyama M, Cherutich P, Lizcano J, Kurth A, Muller A. Barriers to and impacts of hepatitis C treatment among people who inject drugs in Kenya: A qualitative study. PLOS Global Public Health 2025, 5: e0003284. PMID: 39821143, PMCID: PMC11737709, DOI: 10.1371/journal.pgph.0003284.Peer-Reviewed Original ResearchDrop-in-centersRhodes' risk environment framework,HCV-related stigmaReduce barriers to treatmentSystem-level changesBarriers to treatmentMiddle-income countriesTreatment programsBarriers to HCV treatmentRisk environment frameworkExperiences of PWIDHCV treatment programSemi-structured interviewsBarriers patientsHCV treatmentLMIC settingsTranscribed interviewsThematic analysisCase managementQualitative studyPositive treatment outcomesTreatment accessRisk behaviorsImplementing treatment programsPWID
2024
Widespread hepatitis C virus transmission network among people who inject drugs in Kenya
Akiyama M, Khudyakov Y, Ramachandran S, Riback L, Ackerman M, Nyakowa M, Arthur L, Lizcano J, Walker J, Cherutich P, Kurth A. Widespread hepatitis C virus transmission network among people who inject drugs in Kenya. International Journal Of Infectious Diseases 2024, 147: 107215. PMID: 39182826, PMCID: PMC11531246, DOI: 10.1016/j.ijid.2024.107215.Peer-Reviewed Original ResearchGlobal Hepatitis Outbreak and Surveillance TechnologyHepatitis C virusHepatitis C virus strainsTransmission clustersHCV transmission networksHepatitis C virus eliminationHepatitis C virus burdenHypervariable region 1C virusGenotype 1aCity of MombasaInjected drugsCoastal city of MombasaNext-generation sequencing dataHepatitis C virus hypervariable region 1PWIDSyringe programsSequence dataSurveillance technologiesDrugIncome countriesKilifiNairobiPolysubstance Use and Related Risk Behaviors among People Who Inject Drugs in Kenya Preparing for Hepatitis C Virus Treatment
Riback L, Nyakowa M, Lizcano J, Zhang C, Cherutich P, Kurth A, Akiyama M. Polysubstance Use and Related Risk Behaviors among People Who Inject Drugs in Kenya Preparing for Hepatitis C Virus Treatment. Viruses 2024, 16: 1277. PMID: 39205251, PMCID: PMC11359571, DOI: 10.3390/v16081277.Peer-Reviewed Original ResearchMedication-assisted treatmentInjection drug usePolysubstance useHepatitis C virusReducing injection drug useBloodborne infectionsHepatitis C virus treatmentAssociated with injection drug useHepatitis C virus transmissionCannabis useMultivariate logistic regressionEquipment sharingCannabisDrug useHIV-positiveHCV treatmentAcquisition riskHeroinC virusPolysubstanceRisk behaviorsInjected drugsAccess needleRelated risk behaviorsRe-infectionThe “15-Minute City” Concept in the Context of the COVID-19 Pandemic and Climate Change
Vlahov D, Kurth A. The “15-Minute City” Concept in the Context of the COVID-19 Pandemic and Climate Change. Journal Of Urban Health 2024, 101: 669-671. PMID: 39026127, PMCID: PMC11329452, DOI: 10.1007/s11524-024-00897-1.Peer-Reviewed Original Research
News
News
Get In Touch
Contacts
Email